Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C31H38N6O2 |
Molecular Weight | 526.6724 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@H](C)N1C=C(C)C2=C1C=C(C=C2C(=O)NCC3=C(C)C=C(C)NC3=O)C4=CC=C(N=C4)N5CCNCC5
InChI
InChIKey=FKSFKBQGSFSOSM-QFIPXVFZSA-N
InChI=1S/C31H38N6O2/c1-6-22(5)37-18-20(3)29-25(30(38)34-17-26-19(2)13-21(4)35-31(26)39)14-24(15-27(29)37)23-7-8-28(33-16-23)36-11-9-32-10-12-36/h7-8,13-16,18,22,32H,6,9-12,17H2,1-5H3,(H,34,38)(H,35,39)/t22-/m0/s1
Molecular Formula | C31H38N6O2 |
Molecular Weight | 526.6724 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:28:26 GMT 2023
by
admin
on
Sat Dec 16 11:28:26 GMT 2023
|
Record UNII |
W4OGW9QZ97
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
W4OGW9QZ97
Created by
admin on Sat Dec 16 11:28:26 GMT 2023 , Edited by admin on Sat Dec 16 11:28:26 GMT 2023
|
PRIMARY | |||
|
DTXSID301025739
Created by
admin on Sat Dec 16 11:28:26 GMT 2023 , Edited by admin on Sat Dec 16 11:28:26 GMT 2023
|
PRIMARY | |||
|
300000042352
Created by
admin on Sat Dec 16 11:28:26 GMT 2023 , Edited by admin on Sat Dec 16 11:28:26 GMT 2023
|
PRIMARY | |||
|
68210102
Created by
admin on Sat Dec 16 11:28:26 GMT 2023 , Edited by admin on Sat Dec 16 11:28:26 GMT 2023
|
PRIMARY | |||
|
1346574-57-9
Created by
admin on Sat Dec 16 11:28:26 GMT 2023 , Edited by admin on Sat Dec 16 11:28:26 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
The maximal dose and schedule attained with GSK2816126 has shown insufficient evidence of clinical activity, and does not justify further clinical investigation.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |